FDA Clears Hitachi CT System

Julie Ritzer Ross | | Radiology Business | Business Intelligence
imageHitachi Medical Systems America yesterday announced that it has received FDA clearance to market its SCENARIA ™ 64-slice CT system in the U.S. The system is configured to support routine and advanced applications, says Mark Silverman, Hitachi’s manager of CT marketing. Its suite of enhanced dose reduction and awareness features includes Intelli IP™ Iterative Reconstruction and Intelli EC™ 3D automatic exposure control, as well as a Dose Check component that notifies the operator before scanning if a selected scan protocol will result in a patient dose higher than reference levels. A slimmer gantry design with a wider, 75-mm aperture and a lateral shifting table offer ergonomic benefits, according to the vendor.

Julie Ritzer Ross,

Contributor

Related Content

Orano Med breaks ground on $265M thorium production site
Image-interpretation market scoreboard: Radiologists 72%, others 28%
Lantheus lands rights to budding radiopharmaceuticals for initial outlay of $35M
17 short-term strategies to address the national radiologist shortage
‘SR’ onboards another independent practice, its 1st in the Natural State
Analysis: Allied radiology professionals generate millions of dollars per year in indirect revenues alone

Around the web

Health Imaging
Nearly $800,000 settlement offered to family of man who died during MRI exam

The patient, who was being cared for in the ICU, was not accompanied or monitored by nursing staff during his exam, despite being sedated.

Cardiovascular Business
Global shortage of nuclear imaging isotopes may be over

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

Cardiovascular Business
‘A huge win’: CMS significantly increases Medicare payments for cardiac CT

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.